Niche Market Focus Target the haemostasis and point-of-care testing segment with iLine Microsystems' microfluidics and Lab-on-a-Chip technologies, emphasizing their flagship microINR system for anti-vitamin K monitoring as a primary entry point.

Quality & Compliance Leverage their commitment to stringent quality standards and patent-pending technology to position proposals around regulatory readiness, clinical reliability, and robust IP protection for hospital labs and outpatient clinics.

Growth Constraints Recognize the small company size and early revenue stage as opportunities to offer scalable deployment models, faster ROI pilots, and co-development funding options to accelerate market entry.

Digital & Enablement Highlight capabilities to modernize IT and data workflows, given their current tech stack and cloud-based tools, by proposing integrations with LIS/EMR systems, analytics dashboards, and telemedicine platforms for remote INR management.

Funding & Partnerships Position collaborations, grant opportunities, and strategic partnerships to support product development, regulatory submissions, and broader distribution, aligning with their modest funding and growth ambitions.